10-K.Info (Beta Test)
Courtesy of Short Sands, LLC
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

PFIZER INC

Ticker: PFE   Fiscal Year: 2016

Consolidated Balance Sheets

Period Ending Dec 31, 2016 10-K (Filed: Feb 23, 2017)

(In Millions, except shares in actual)
 As ofAs of
 Dec 31, 2016Dec 31, 2015
Assets
Cash and cash equivalents
$
2,595
3,641
Short-term investments15,25519,649
Trade accounts receivable, less allowance for doubtful accounts: 2016$609; 2015$3848,225 [1]8,176
Inventories6,783 [2]7,513
Current tax assets3,0412,662
Other current assets2,2492,154
Assets held for sale8019
Total current assets38,94943,804
 
Long-term investments7,11615,999
Property, plant and equipment, less accumulated depreciation13,318 [3]13,766
Identifiable intangible assets, less accumulated amortization52,64840,356
Goodwill54,44948,242
Noncurrent deferred tax assets and other noncurrent tax assets1,8121,794
Other noncurrent assets3,3233,420
Total assets171,615167,381
 
Liabilities and Equity
Short-term borrowings, including current portion of long-term debt: 2016$4,225; 2015$3,71910,68810,159 [4]
Trade accounts payable4,5363,620
Dividends payable1,9441,852
Income taxes payable437418
Accrued compensation and related items2,4872,359
Other current liabilities11,02310,990
Total current liabilities31,11529,399
 
Long-term debt31,39828,740 [5]
Pension benefit obligations, net6,4066,310
Postretirement benefit obligations, net1,7661,809
Noncurrent deferred tax liabilities30,75326,877
Other taxes payable4,0003,992
Other noncurrent liabilities6,3375,257
Total liabilities111,776102,384
 
Commitments and Contingencies  
Preferred stock, no par value, at stated value; 27 shares authorized; issued: 2016597; 20156492426
Common stock, $0.05 par value; 12,000 shares authorized; issued: 20169,230; 20159,178461459
Additional paid-in capital82,68581,016
Treasury stock, shares at cost: 20163,160; 20153,003(84,364)(79,252)
Retained earnings71,77471,993
Accumulated other comprehensive loss(11,036)(9,522)
Total Pfizer Inc. shareholders equity59,54464,720
 
Equity attributable to noncontrolling interests296278
Total equity59,84064,998
 
Total liabilities and equity171,615167,381
 
[1] Amounts may not add due to rounding.
[2] The change from December 31, 2015 reflects, among other things, the reclassification of $377 million to Assets held for sale (see Note 2B).
[3] Reflects legacy Medivation and legacy Anacor amounts in 2016, commencing on the Medivation acquisition date, September 28, 2016, and Anacor acquisition date, June 24, 2016. Reflects legacy Hospira amounts in 2016 and 2015 commencing on the Hospira acquisition date, September 3, 2015. | The decrease in total property, plant and equipment is primarily due to depreciation, the reclassification of $457 million to Assets held for sale (see Note 2B) and, to a lesser extent, impairments and the impact of foreign e
[4] The differences between the estimated fair values and carrying values of held-to-maturity debt securities, private equity securities at cost-method and short-term borrowings not measured at fair value on a recurring basis were not significant as of December 31, 2016 or December 31, 2015. The fair value measurements of our held-to-maturity debt securities and our short-term borrowings are based on Level 2 inputs, using a market approach. The fair value measurements of our private equity securities carried at
[5] The fair value of our long-term debt (not including the current portion of long-term debt) was $34.9 billion as of December 31, 2016 and $32.7 billion as of December 31, 2015. The fair value measurements for our long-term debt are based on Level 2 inputs, using a market approach.
External Links 
PFIZER INC (PFE) Fiscal Year 2016
Statements of 10-K in Excel https://www.sec.gov/.../Financial.xlxs
Complete 10-K in HTML https://www.sec.gov/.../10-K.html
Complete 10-K in XBRL https://www.sec.gov/.../10-K-xbrl.zip